trial · primary record
GD2, PSMA and CD276 CAR-T cells
Neuroblastoma
| Phase | Phase 1, Phase 2 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 100 |
| Primary completion | 2030-12-31 |
| Primary endpoint | Number of patients with adverse events |
| Registry ID | NCT04637503 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-30T14:43:23.242Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT04637503
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.